Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-κB ligand

被引:71
作者
Buckley, KA
Hipskind, RA
Gartland, A
Bowler, WB
Gallagher, JA
机构
[1] Univ Liverpool, Dept Human Anat & Cell Biol, New Med Sch, Human Bone Cell Res Grp, Liverpool L69 3GE, Merseyside, England
[2] CNRS, UMR 5535, Inst Genet Mol Montpellier, Montpellier, France
[3] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA
关键词
adenosine triphosphate (ATP); osteoclast; receptor activator of nuclear factor-kappa B ligand (RANKL); P-2; receptor; resorption; osteoblast;
D O I
10.1016/S8756-3282(02)00877-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nucleotides such as adenosine triphosphate (ATP) and uridine triphosphate (UTP) exist in the extracellular environment where they are agonists at P2 receptors. Both P2Y G-protein-coupled receptors and P2X ligand-gated ion channels are expressed by osteoblasts and osteoclasts, reflected in the diverse nucleotide-induced effects reported to occur in bone. Previous reports have implicated ATP as a proresorptive agent; however, these studies were unable to determine whether ATP mediated its actions directly on osteoclasts, or indirectly via osteoblasts. The development of techniques to generate human osteoclasts in vitro has allowed us to further investigate the intriguing role of extracellular nucleotides with regard to osteoclast activity. This study reports that nearly all P2-receptor-subtype mRNAs were expressed throughout human osteoclast development, and provides evidence for functional P2 receptor expression by these cells. In cultures of human osteoclasts alone, neither ATP nor UTP affected the quantity of resorption by these cells; however, in cocultures of osteoblast-like UMR-106 cells and human osteoclasts, ATP, but not UTP, greatly enhanced resorption, indicating a role for osteoblasts in mediating the proresorptive effects of ATP. Furthermore, ATP, but not UTP, elevated receptor activator of nuclear factor-kappaB ligand (RANKL) mRNA and protein expression by UMR-106 cells. These data are consistent with observations that UMR-106 cells predominantly express P2Y(1) with low expression of P2Y(2), thereby explaining the response to ATP and not UTP, and further substantiating the involvement of osteoblasts in ATP-induced effects on osteoclasts. These results significantly advance our understanding of the role of P2 receptors in bone, and indicate that local-acting ATP may play a pivotal role in osteoclast activation at bone-resorbing sites by, inducing elevated expression of RANKL.
引用
收藏
页码:582 / 590
页数:9
相关论文
共 45 条
  • [11] Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X(7) receptor
    Chiozzi, P
    Sanz, JM
    Ferrari, D
    Falzoni, S
    Aleotti, A
    Buell, GN
    Collo, G
    DiVirgilio, F
    [J]. JOURNAL OF CELL BIOLOGY, 1997, 138 (03) : 697 - 706
  • [12] SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION
    CHOMCZYNSKI, P
    SACCHI, N
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) : 156 - 159
  • [13] Gartland A, 2000, J BONE MINER RES, V15, P1227
  • [14] Gartland A., 1999, Calcified Tissue International, V64, pS56
  • [15] Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint
    Haynes, DR
    Crotti, TN
    Loric, M
    Bain, GI
    Atkins, GJ
    Findlay, DM
    [J]. RHEUMATOLOGY, 2001, 40 (06) : 623 - 630
  • [16] Extracellular ADP is a powerful osteolytic agent:: evidence for signaling through the P2Y1 receptor on bone cells
    Hoebertz, A
    Meghji, S
    Burnstock, G
    Arnett, TR
    [J]. FASEB JOURNAL, 2001, 15 (07) : 1139 - 1148
  • [17] Expression of P2 receptors in bone and cultured bone cells
    Hoebertz, A
    Townsend-Nicholson, A
    Glass, R
    Burnstock, G
    Arnett, TR
    [J]. BONE, 2000, 27 (04) : 503 - 510
  • [18] Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells.
    Horwood, NJ
    Elliott, J
    Martin, TJ
    Gillespie, MT
    [J]. ENDOCRINOLOGY, 1998, 139 (11) : 4743 - 4746
  • [19] Expression of osteoprotegerin, receptor activator of NF-κB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing
    Kon, T
    Cho, TJ
    Aizawa, T
    Yamazaki, M
    Nooh, N
    Graves, D
    Gerstenfeld, LC
    Einhorn, TA
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (06) : 1004 - 1014
  • [20] Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations
    Lazarowski, ER
    Boucher, RC
    Harden, TK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (40) : 31061 - 31068